Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Guangdong Bawei BiotechnologyBJSE:920123 42 ROA % is 4.45% as of Mar. 2026, which is 43% below its 10-year median of 7.80. GuruFocus rates BJSE:920123 with a GF Score™ of 42/100. The stock has 4 warning signs investors should review. Among 2,002 Consumer Packaged Goods companies, Guangdong Bawei Biotechnology ranks better than 57.34% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Guangdong Bawei Biotechnology's annualizedNet Income for the quarter that ended in Mar. 2026 was ¥40.0 Mil.
Guangdong Bawei Biotechnology's average Total Assets over the quarter that ended in Mar. 2026 was ¥897.6 Mil. Therefore, Guangdong Bawei Biotechnology's annualized ROA % for the quarter that ended in Mar. 2026 was 4.45%.
The historical rank and industry rank for Guangdong Bawei Biotechnology's ROA % or its related term are showing as below:
BJSE:920123'
s ROA % Range Over the Past 10 Years
Min: 4.25 Med: 7.8 Max: 18.67
Current: 4.64
During the past 13 years, Guangdong Bawei Biotechnology's highest ROA % was 18.67%. The lowest was 4.25%. And the median was 7.80%.
BJSE:920123's ROA % is ranked better than 57.34% of 2002
companies
in the Consumer Packaged Goods industry
Industry Median: 3.345
vs BJSE:920123: 4.64
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Guangdong Bawei Biotechnology ROA % Related Terms
Guangdong Bawei Biotechnology ROA % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, Guangdong Bawei Biotechnology's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guangdong Bawei Biotechnology ROA % vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Guangdong Bawei Biotechnology's ROA % distribution charts can be found below:
* The bar in red indicates where Guangdong Bawei Biotechnology's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
Guangdong Bawei Biotechnology (BJSE:920123) has a ROA % of 4.45% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guangdong Bawei Biotechnology and its competitors. This is 43% below median its historical median of 7.80. Over the past decade, Guangdong Bawei Biotechnology's ROA % has ranged from 4.25 to 18.67. According to the industry distribution chart, Guangdong Bawei Biotechnology ranks #854 out of 2002 companies in the Consumer Packaged Goods industry, placing it in the top 42.7%.
Is Guangdong Bawei Biotechnology's ROA % too high?
Guangdong Bawei Biotechnology's current ROA % of 4.45% is 43% below median its 10-year median of 7.80. Over the past 10 years, this metric has ranged from a low of 4.25 to a high of 18.67. The Consumer Packaged Goods industry median ROA % is 3.35. Guangdong Bawei Biotechnology's value of 4.45% is 33% above this industry median. Based on the distribution chart, Guangdong Bawei Biotechnology ranks #854 out of 2002 companies in the Consumer Packaged Goods industry, which is above the industry midpoint. Overall, Guangdong Bawei Biotechnology has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guangdong Bawei Biotechnology's ROA % compare to PG and CL?
According to the Consumer Packaged Goods industry distribution chart, Guangdong Bawei Biotechnology ranks #854 out of 2002 companies for ROA %. This puts Guangdong Bawei Biotechnology in the upper half of its industry. The industry median ROA % is 3.35. Guangdong Bawei Biotechnology's value of 4.45% is 33% above this benchmark. Historically, Guangdong Bawei Biotechnology's own ROA % has ranged from 4.25 to 18.67 over the past decade. While the company's 10-year median is 7.80 vs. the industry median of 3.35, Guangdong Bawei Biotechnology has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Consumer Packaged Goods company?
The median ROA % among Consumer Packaged Goods companies is 3.35, based on 2,002 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Guangdong Bawei Biotechnology's current ROA % of 4.45% is 33% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Guangdong Bawei Biotechnology and its competitors. For the Consumer Packaged Goods industry, the median ROA % is 3.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guangdong Bawei Biotechnology's current ROA % is 4.45%, which is 43% below median its own 10-year median of 7.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangdong Bawei Biotechnology stock overvalued right now?
Guangdong Bawei Biotechnology (BJSE:920123) has a current ROA % of 4.45%. The current ROA % is 4.45%, which is 43% below median its 10-year median of 7.80 and 33% above the Consumer Packaged Goods industry median of 3.35. Guangdong Bawei Biotechnology's overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Guangdong Bawei Biotechnology (BJSE:920123), the current ROA % is 4.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920123 has been successfully added to your 
